* Champions Oncology Inc CSBR.OQ reported a quarterly adjusted
loss of 1 cents per share for the quarter ended in July. The
mean expectation of two analysts for the quarter was
for earnings of one cents per share.
* Revenue rose 17.9% to $11.25 million from a year ago;
analysts expected $10.98 million.
* Champions Oncology Inc's reported EPS for the quarter was a
loss of 1 cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Champions Oncology Inc shares had fallen by 2.7% this
quarter and lost 7.3% so far this year.
* The company reported a quarterly loss of $172 thousand.
* Wall Street's median 12-month price target for Champions
Oncology Inc is $16.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated September 13 at 09:48 p.m.
All figures in US dollars unless otherwise stated